Lincoln National Corp’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,922
| Closed | -$204K | – | 894 |
|
|
2022
Q1 | $204K | Sell |
5,922
-8,176
| -58% | -$282K | ﹤0.01% | 862 |
|
|
2021
Q4 | $618K | Sell |
14,098
-922
| -6% | -$40.4K | 0.01% | 458 |
|
|
2021
Q3 | $762K | Sell |
15,020
-201
| -1% | -$10.2K | 0.02% | 388 |
|
|
2021
Q2 | $792K | Sell |
15,221
-2,286
| -13% | -$119K | 0.02% | 370 |
|
|
2021
Q1 | $800K | Buy |
17,507
+500
| +3% | +$22.8K | 0.02% | 336 |
|
|
2020
Q4 | $781K | Buy |
17,007
+1,125
| +7% | +$51.7K | 0.02% | 323 |
|
|
2020
Q3 | $619K | Buy |
+15,882
| New | +$619K | 0.02% | 338 |
|